Not a good buy right now: price is breaking down intraday (-7.54%) with bearish momentum signals and weak fundamentals.
No Intellectia buy signals (AI Stock Picker/SwingMax), no news catalyst, and the short-term pattern stats lean negative (next week expected -2.65%).
For an impatient investor unwilling to wait for a cleaner entry, the odds favor further downside/whipsaw rather than an immediate reward setup.
Technical Analysis
Trend/Momentum: MACD histogram at -0.401 (below 0) with negative momentum still present (even if contracting), consistent with a bearish-to-weak trend.
RSI(6) 41.2: neutral-to-bearish, not oversold enough to suggest a high-conviction bounce.
Key levels: Current 7.85 is below pivot 7.964 (bearish). Near-term resistance at 8.991; supports at 6.936 then 6.301.
Moving averages: converging (no strong uptrend); combined with today’s sharp drop, this favors “avoid catching the falling knife.”
Quant pattern read-through: Similar candlestick patterns imply ~0.14% next day, -2.65% next week, +1.2% next month—near-term skew is negative.
Positive Catalysts
MACD is negatively contracting (selling pressure may be slowing), allowing for short-lived technical bounces.
No heavy hedge-fund/insider selling trend flagged (both neutral), reducing the risk of a confirmed distribution signal from these cohorts.
Neutral/Negative Catalysts
creates a poor immediate risk/reward for an impatient entry.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 1,653,776, down -32.24% YoY (clear contraction).
Net income: -3,451,950 (loss widened slightly; -2.52% YoY indicates still deeply unprofitable).
EPS: -1.18, down -98.55% YoY (major deterioration).
Gross margin: 42.73%, down -7.01% YoY (profitability pressure).
Overall: weakening growth and margins do not support an aggressive “buy now” stance.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data provided, so Wall Street consensus trends cannot be confirmed.
Practical pro/con view from available data: Pros—potential for technical dead-cat bounces; neutral hedge/insider trend. Cons—falling revenue, deep losses, deteriorating EPS, and weak price action.
Wall Street analysts forecast DBGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DBGI is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast DBGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DBGI is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
